The idea that mental disorders are caused by a biological mechanism is linked with prolonged use of antidepressants and ...

Ustekinumab showed longer drug survival than adalimumab and secukinumab in biologic-naive psoriasis patients in Denmark. Bimekizumab, guselkumab, and risankizumab had lower discontinuation risks in ...

A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort ...

Biologics remain viable options with varying persistence over 1 year in patients with inflammatory bowel disease.

Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at ...

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...

Biologic drugs are a newer treatment option for chronic rhinosinusitis with nasal polyps. They work differently from other treatments. Nasal polyps are small, noncancerous growths that develop in the ...

SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for ...